Table 2 Tumour characteristics in the 1st line endocrine setting (n = 16)
From: Treatment of hormone positive uterine leiomyosarcoma with aromatase inhibitors
| Variable | n = 16 (%) |
|---|---|
| Histological grade (Stanford) | |
| Low | 8 (50%) |
| High | 8 (50%) |
| Histological grade (FNCLCC) | |
| Low | 7 (44%) |
| Intermediate | 3 (19%) |
| High | 6 (37%) |
| Hormone receptor status | |
| ER | |
| Moderate to strong (grade 2–3) | 13 (81%) |
| Weak (grade 1) | 3 (19%) |
| PgR | |
| Moderate to strong (grade 2–3) | 10 (62.5%) |
| Weak (grade 1) | 6 (37.5%) |
| ER and PgR | |
| Moderate to strong (grade 2–3) | 10 (62.5%) |
| Weak (grade 1) | 2 (12.5%) |
| % ER staining | |
| >90% | 10 (62.5%) |
| >50% | 14 (87.5%) |
| 10-50% | 1 (6.25%) |
| Unknown | 1 (6.25%) |
| % PgR staining | |
| >90% | 6 (37.5%) |
| >50% | 11 (68.75%) |
| 10-50% | 1 (6.25%) |
| 0% | 2 (12.5%) |
| unknown | 2 (12.5%) |